Traumatic optic neuropathy management: a systematic review

Richard J. Blanch,Iric John Joseph,Kimberly Cockerham

DOI: https://doi.org/10.1038/s41433-024-03129-7

IF: 4.4563

2024-06-12

Eye

Abstract:Abstract Background Traumatic optic neuropathy is classically described in up to 8% of patients with traumatic brain injury (TBI), but subclinical or undiagnosed optic nerve damage is much more common. When more sensitive testing is performed, at least half of patients with moderate to severe TBI demonstrate visual field defects or optic atrophy on examination with optical coherence tomography. Acute optic nerve compression and ischaemia in orbital compartment syndrome require urgent surgical and medical intervention to lower the intraocular pressure and diminish the risk of permanent optic nerve dysfunction. Other manifestations of traumatic optic neuropathy have more variable treatments in international practice. Methods We conducted a systematic review of traumatic optic neuropathy treatments in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement. Results We included three randomised controlled trials of intravenous methylprednisolone (IVMP), erythropoietin, and levodopa-carbidopa combination, with no evidence of benefit for any treatment. In addition, large studies in TBI have found strong evidence of increased mortality in patients treated with megadose IVMP. Conclusions There is therefore no evidence of benefit for any medical treatment and strong evidence of harm from IVMP. There is also no evidence of benefit for optic canal decompression for traumatic optic neuropathy. Orbital compartment syndrome is a separate entity that requires both medical and surgical interventions to prevent visual loss.

ophthalmology

What problem does this paper attempt to address?

The paper attempts to address the issue of effective treatment methods for Traumatic Optic Neuropathy (TON). Specifically, the paper evaluates the effectiveness of various drugs and surgical methods used to treat TON through a systematic review, including Intravenous Methylprednisolone (IVMP), Erythropoietin (EPO), and Levodopa-Carbidopa combination therapy. The study found that these treatments have no significant efficacy and that high doses of IVMP carry a risk of increased mortality. Additionally, the paper discusses the management of Orbital Compartment Syndrome, emphasizing the importance of emergency decompression. Overall, the paper aims to provide scientific evidence for the clinical management of TON and points out the shortcomings of current treatment methods.